{"id":"W2149286249","doi":"10.1158/1078-0432.ccr-06-1165","title":"A Phase I Pharmacokinetic and Pharmacodynamic Study of Intravenous Calcitriol in Combination with Oral Gefitinib in Patients with Advanced Solid Tumors","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":90,"is_retracted":false,"has_abstract":true,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Calcitriol; Gefitinib; Medicine; Pharmacology; Pharmacokinetics; Pharmacodynamics; Epidermal growth factor receptor; Tyrosine-kinase inhibitor; Vandetanib; Protein kinase B; Internal medicine; Dosing; Endocrinology; Tyrosine kinase; Cancer; Chemistry; Receptor; Signal transduction; Vitamin D and neurology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00277524,0.0001838616,0.0005729782,0.0004276033,0.00007627244,0.000007908163,0.0002764063,0.0001391301,0.0001568683],"category_scores_gemma":[0.0001370404,0.0001455822,0.00002426219,0.0007725779,0.0007824179,0.00009935509,0.0001315064,0.001423429,0.00000681707],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002177719,"about_ca_system_score_gemma":0.0002419484,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009246164,"about_ca_topic_score_gemma":0.001878232,"domain_scores_codex":[0.99695,0.0007613554,0.000877517,0.0005168258,0.0002139129,0.0006804287],"domain_scores_gemma":[0.998354,0.0007942804,0.0001912888,0.0002457551,0.0003614508,0.00005322904],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04167564,0.02017128,0.6013944,0.0001057862,0.0001868317,0.00009657429,0.002090656,0.000141554,0.012479,0.00001174493,0.00004522279,0.3216013],"study_design_scores_gemma":[0.1470388,0.02540088,0.8139466,0.0003388128,0.00004734004,0.000004586976,0.001400906,0.00007884673,0.01106916,0.00002674181,0.0003241998,0.0003231299],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968324,0.0008820981,0.00001806394,0.00004173028,0.000209895,0.001869549,0.00001858712,0.00001361105,0.0001140246],"genre_scores_gemma":[0.9994124,0.0002073948,0.000024436,0.00004583898,0.00001490207,0.000147934,0.00002728069,0.00003010727,0.00008970091],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3212782,"threshold_uncertainty_score":0.618417,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06016743687366678,"score_gpt":0.480103932089061,"score_spread":0.4199364952153942,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}